Carroll Financial Associates’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-450
Closed -$7K 1638
2021
Q3
$7K Buy
+450
New +$7.72K ﹤0.01% 1307
2020
Q3
Sell
-2,460
Closed -$59K 1502
2020
Q2
$59K Buy
+2,460
New +$60.7K ﹤0.01% 611
2019
Q4
Sell
-8,620
Closed -$204K 1540
2019
Q3
$204K Buy
+8,620
New +$200K 0.02% 358

Other funds holding BTAL

Carroll Financial Associates's BTAL Position: Q4 2021 in Review

Carroll Financial Associates sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2021, closing a stake of 450 shares — an estimated $7K sold.

Carroll Financial Associates first reported a position in BTAL in Q3 2019 and held it in 3 quarters. The position peaked at $204K in Q3 2019. 25 funds tracked by Wall St. Rank hold BTAL as of Q4 2021.

  • Carroll Financial Associates reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 450 AGF US Market Neutral Anti-Beta Fund shares in Q4 2021, an estimated $7K.
  • Carroll Financial Associates first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2019 and held it in 3 quarters.
  • Carroll Financial Associates's AGF US Market Neutral Anti-Beta Fund position peaked at $204K in Q3 2019.
  • 25 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.